background
rapid
diagnosi
influenza
import
control
outbreak
start
antivir
therapi
direct
antigen
detect
dad
rapid
lack
sensit
wherea
nucleic
acid
amplif
test
nat
sensit
also
timeconsum
object
evalu
perform
rapid
isotherm
nat
two
dad
studi
design
februarymay
test
consecut
patient
influenzalik
ill
use
commerci
isotherm
nat
aler
tm
influenza
b
well
dad
sofia
influenza
b
binaxnow
influenza
b
detect
influenzaa
b
viru
commerci
multiplex
nat
serv
refer
test
serial
dilut
influenzaa
b
cell
cultur
supernat
examin
anoth
patient
sampl
test
decemb
result
compar
isotherm
nat
aler
tm
influenza
b
dad
sofia
influenza
b
binaxnow
influenza
b
sensit
specif
respect
first
patient
sampl
aler
tm
influenza
b
show
sensit
specif
second
cohort
isotherm
nat
sensit
compar
dad
influenza
viru
cultur
supernat
lower
limit
detect
copiesml
averag
turnaround
time
tat
isotherm
nat
dad
min
increas
min
aler
tm
influenza
b
min
binaxnow
influenza
b
min
sofia
influenza
b
analyz
batch
sampl
conclus
simpl
sampl
process
tat
min
render
isotherm
nat
aler
tm
influenza
b
suitabl
sequenti
nearpati
test
tat
advantag
lost
test
larger
seri
communityacquir
respiratori
viru
isotherm
pcr
turnaround
time
tat
antigen
detect
nucleic
acid
amplif
test
nat
b
r
c
background
rapid
diagnosi
influenza
import
control
outbreak
start
antivir
therapi
direct
antigen
detect
dad
rapid
lack
sensit
wherea
nucleic
acid
amplif
test
nat
sensit
also
timeconsum
object
evalu
perform
rapid
isotherm
nat
two
dad
studi
design
februarymay
test
consecut
patient
influenzalik
ill
use
commerci
isotherm
nat
aler
tm
influenza
b
well
dad
sofia
influenza
b
binaxnow
influenza
b
detect
influenzaa
b
viru
commerci
multiplex
nat
serv
refer
test
serial
dilut
influenzaa
b
cell
cultur
supernat
examin
anoth
patient
sampl
test
decemb
result
compar
isotherm
nat
aler
tm
influenza
b
dad
sofia
influenza
b
binaxnow
influenza
b
sensit
specif
respect
first
patient
sampl
aler
tm
influenza
b
show
sensit
specif
second
cohort
isotherm
nat
sensit
compar
dad
influenza
viru
cultur
supernat
lower
limit
detect
copiesml
averag
turnaround
time
tat
isotherm
nat
dad
min
increas
min
aler
tm
influenza
b
min
binaxnow
influenza
b
min
sofia
influenza
b
analyz
batch
sampl
conclus
simpl
sampl
process
tat
min
render
isotherm
nat
aler
tm
influenza
b
suitabl
sequenti
nearpati
test
tat
advantag
lost
test
larger
seri
elsevi
bv
right
reserv
rapid
sensit
diagnost
test
influenza
viru
permit
time
treatment
decis
infect
control
measur
emerg
room
hospit
ward
nurs
home
current
method
use
laboratori
diagnosi
influenza
includ
viru
isol
cell
cultur
direct
antigen
detect
dad
nucleic
acid
amplif
test
nat
viru
isol
cell
cultur
permit
identif
infecti
viru
fairli
high
sensit
timeand
resourceconsum
larg
limit
special
laboratori
dad
wide
use
short
turnaround
time
tat
limit
lower
sensit
especi
adult
patient
present
sever
day
symptom
onset
nat
character
high
sensit
specif
semiquantif
realtim
format
amen
autom
multiplex
howev
nat
requir
molecular
diagnost
laboratori
skill
personnel
appropri
instrument
rare
deliv
result
tat
h
evalu
perform
isotherm
pcr
influenza
aler
tm
influenza
b
two
dad
sofia
influenza
b
binaxnow
influenza
b
versu
commerci
multiplex
nat
februari
may
test
first
cohort
consecut
nasopharyng
swab
patient
influenzalik
ill
isotherm
nat
aler
tm
discord
sampl
resolv
inhous
qnat
influenza
tat
h
total
nucleic
acid
extract
ul
respiratori
sampl
use
corbett
system
qiagen
hilden
germani
total
sampl
posit
influenzaa
perform
three
rapid
test
compar
refer
method
influenzaa
b
combin
shown
tabl
use
multiplex
nat
refer
aler
tm
influenza
b
sofia
influenza
b
binaxnow
influenzaa
b
sensit
specif
respect
specif
test
could
confirm
influenzaneg
sampl
test
n
multiplex
nat
detect
pathogen
sampl
includ
rhinovirusenteroviru
coronaviru
human
bocaviru
rsv
rsv
b
adenoviru
human
metapneumoviru
bacteria
bordetella
pertussi
mycoplasma
pneumonia
none
falseneg
sampl
posit
anoth
pathogen
overal
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
valu
interobserv
agreement
influenzaa
b
slightli
higher
specimen
pediatr
patient
limit
detect
test
evalu
use
serial
dilut
fresh
cell
cultur
supernat
influenzaa
influenzab
grown
cell
fig
influenzaa
detect
limit
aler
tm
influenza
b
accord
qnat
approxim
geqml
geqml
geqml
influenzab
overal
sensit
dad
sofia
influenza
b
tabl
perform
dilut
directli
test
use
aler
tm
influenza
b
aler
triangl
sofia
influenza
b
sofia
circl
binaxnow
influenza
b
binax
squar
parallel
dilut
extract
quantifi
qnat
describ
studi
design
solid
symbol
posit
test
open
symbol
neg
test
line
lower
limit
detect
indic
rapid
test
hatch
area
limit
detect
influenza
qnat
binaxnow
influenza
b
order
magnitud
lower
aler
tm
influenza
b
prospect
studi
overal
sensit
specif
aler
tm
influenza
b
assay
influenza
sever
factor
may
play
role
larg
number
sampl
n
first
cohort
obtain
toward
end
influenza
season
februari
may
decreas
posit
rate
pretest
probabl
sampl
analyz
retrospect
frozen
sampl
manufactur
recommend
use
fresh
sampl
exclud
sampl
analysi
sensit
increas
specif
possibl
test
use
highgrad
extractionamplif
procedur
less
affect
test
frozen
sampl
even
lower
amount
influenza
viru
aler
tm
influenza
b
sampl
result
discord
result
aler
tm
influenza
b
assay
viral
qnat
load
geqml
influenzaa
b
cell
cultur
estim
limit
detect
around
geqml
aler
tm
influenza
b
therefor
patient
lower
viral
load
might
identifi
independ
conclus
assay
perform
studi
report
sensit
aler
tm
influenza
b
influenzaa
influenzab
specif
influenzaa
influenzab
aler
tm
influenza
b
yield
falseposit
result
among
sampl
falseposit
among
sampl
rate
correspond
among
symptomat
patient
would
unjustifi
treat
isol
convers
antivir
treatment
would
withheld
patient
test
neg
data
suggest
test
patient
improv
time
deliveri
antivir
per
infect
would
receiv
treatment
clinic
impact
may
differ
depend
clinic
scenario
hospit
patient
like
confirm
cours
diseas
wherea
outpati
less
like
retest
unless
symptom
persist
current
studi
indic
isotherm
nat
provid
aler
tm
influenza
b
significantli
faster
convent
qnat
min
versu
h
multiplex
nat
h
compar
dad
sampl
prepar
equal
simpl
aler
tm
influenza
b
could
potenti
perform
outsid
molecular
diagnost
laboratori
set
eg
physician
offic
emerg
room
could
save
transport
time
laboratori
howev
care
need
taken
individu
oper
system
properli
train
certifi
singl
sampl
test
howev
run
larger
number
patient
sampl
becom
challeng
tat
advantag
isotherm
pcr
lost
taken
togeth
aler
tm
influenza
b
reduc
tat
compar
multiplex
nat
qnat
sensit
specif
compar
convent
nat
refer
test
superior
two
dad
assay
aler
tm
influenza
b
may
attract
firstlin
rapid
test
individu
patient
present
health
care
follow
qnat
multiplex
nat
inform
rel
amount
presenc
virus
need
none
none
declar
requir
